A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. - Wikidata - wikimedia - TriplyDB

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.

http://www.wikidata.org/entity/Q34369987

about

Intestinal microbiota transplant - current state of knowledge Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease The Gut Microbiota in Immune-Mediated Inflammatory Diseases The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection Molecular Players Involved in the Interaction Between Beneficial Bacteria and the Immune System Microbiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBD Intestinal Microbiota in Animal Models of Inflammatory Diseases Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease Intestinal permeability--a new target for disease prevention and therapy Microbiome, Metabolome and Inflammatory Bowel Disease Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut Gut Microbiota and Host Reaction in Liver Diseases The Microbiome and Sustainable Healthcare.Oral Administration of Faecalibacterium prausnitzii Decreased the Incidence of Severe Diarrhea and Related Mortality Rate and Increased Weight Gain in Preweaned Dairy Heifers Gut microbiota and colorectal cancer.Multilevel regularized regression for simultaneous taxa selection and network construction with metagenomic count data.Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.Can we change our microbiome to prevent colorectal cancer development?Differential expression of GPR15 on T cells during ulcerative colitis.Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome.The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.Effects of Commercial Apple Varieties on Human Gut Microbiota Composition and Metabolic Output Using an In Vitro Colonic Model.Comparisons of Gut Microbiota Among Healthy Control, Patients With Conventional Adenoma, Sessile Serrated Adenoma, and Colorectal Cancer Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.Potential and active functions in the gut microbiota of a healthy human cohort The intestinal metabolome: an intersection between microbiota and host.The colonization dynamics of the gut microbiota in tilapia larvae.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity Differential responses of cecal microbiota to fishmeal, Eimeria and Clostridium perfringens in a necrotic enteritis challenge model in chickens.Impact of stressor exposure on the interplay between commensal microbiota and host inflammation Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.Multivariate inference of pathway activity in host immunity and response to therapeutics.Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.Comparison of assembly algorithms for improving rate of metatranscriptomic functional annotation Human genetics shape the gut microbiome.

P2860

Q26741017-0D307AD9-4CA9-43B6-8B5E-1586FDA33ED9 Q26741117-5ED42D01-A48E-4159-AE5D-2493201EDBAE Q26741414-ADAA079F-E0F3-475D-A69F-DA0331075592 Q26745700-592B69BF-67B3-4256-BF7B-54B21544B430 Q26765857-8621BAF0-4740-4523-95F4-4291B8D1497F Q26771122-16875D0F-3B2C-4BC4-A67F-419B26CAC102 Q26774688-4EEB6533-952B-40CF-B3C4-08F16002DFBB Q26774703-4ACF03AE-3D21-4BB3-AF2A-F52170A6FCA7 Q26779169-7FDE4782-FB34-41C7-8491-91496161AF8A Q26795707-9AEB31C9-8D56-490A-8465-5D915B64A4B3 Q27003192-3992E01F-D80F-4DD9-9BDD-C96C8D93B043 Q27015884-BBFB238E-01D0-41DE-86D2-B451A9CB6AFA Q28078126-E46F34FE-8F05-4412-AE0C-C27DDD114E67 Q28081848-151B50FC-E166-4FE2-8AD4-5271B9142EAB Q28083295-D7CB9168-503E-42CC-ACCF-1928B1D94260 Q28088606-A06310BA-42E7-40D5-92C0-FBA380A01116 Q28603476-08FB90AA-CF5B-4733-ABD2-4113C081E465 Q30239806-FEDAEB53-B5D0-4480-A0BE-8106D90572C9 Q30871031-8B88FCBE-0476-4133-9F09-647A108AD9FC Q30988830-BCAB2AF1-BD9A-44F7-95BE-E835365E56C3 Q33360917-1C8646F7-D90C-477F-A6C3-356216924934 Q33579024-27C1958A-BC1C-4CDC-8EE0-8CF9ADEEA197 Q33612677-F933F8E4-E0E3-44E1-A297-AB93AB583D37 Q33670800-9F6D7C05-8D67-4B4E-B82C-4BAC1078D44B Q33709456-E52CD688-9A24-4020-85AF-5844FDA265B9 Q33851760-07C3C3D1-DEE0-4BF0-B0CD-073704627FA6 Q33888089-78DA5A7A-E2D2-4E16-A0F2-131D562D1FF3 Q33906911-02886DD7-DC40-44ED-A0F8-DC419D4C98EA Q33909976-E1842C09-5B4D-4C43-94A0-CECA21975918 Q33915560-1333302D-9893-49D0-B2B2-03ECA1FC7320 Q33968967-B6B01124-04AD-45D1-A25E-8694B3320A36 Q34048001-6F3E55E0-1510-4F28-A3DE-395CE3AD3DEC Q34104628-03B2FD6A-2148-4B10-B74C-956445C1045D Q34129398-9AEDF789-7448-4677-9750-A20DE2312983 Q34153279-9C6A71ED-CB9E-442E-9326-657743D3476F Q34249561-F898ED58-D431-4B26-A17B-4026CDDC5EE1 Q34409186-96788B21-6A7E-415C-99A8-B32A332A24D9 Q34499080-C330C803-ADC0-43CE-A4B8-D1A929FD2D0F Q34539926-E1C701AF-2E01-4A46-BDD2-1A01CCBAE951 Q34630305-D8B56ECA-18D3-4787-B755-48FE7CC6DE29

P2860

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.

http://www.wikidata.org/entity/Q34369987

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@ast

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@en

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@nl

type

label

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@ast

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@en

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@nl

prefLabel

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@ast

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@en

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@nl

P1433

Q34369987-4F75794E-2D94-44BC-9380-4C7FCCD8730A

P1476

Q34369987-4EDDB54E-2B4B-482C-9555-8797B657BF0D

P2093

Q34369987-159FD56E-6A10-4F49-B3CA-983189555BFD

Q34369987-1FEBC8F8-C163-4F4D-925A-4C118CFE837C

Q34369987-6730EEB6-D612-450C-AE4D-55AF40A770FA

Q34369987-9D426F5E-A359-4F87-9A32-CB225EF8B4A7

Q34369987-D5897107-BB17-4F56-B089-954F7CAF4EFC

Q34369987-D919EDF1-5653-4992-B280-0268C377C5E5

Q34369987-DFE72B03-70E0-4360-B45C-91918158550A

Q34369987-E5381125-865A-4064-9703-33CF431E13CD

Q34369987-F5128303-12ED-44B1-B32E-6DD52015F9EB

P304

Q34369987-751A194A-098F-4561-846B-9C5F94558940

P31

Q34369987-024739C2-9129-4419-8EC7-060555A2A70B

P356

Q34369987-805AF958-E26E-4961-AB75-D90FC6CE45C3

P407

Q34369987-B3BD5B7A-7F55-4D42-8314-DC730FDD3466

P433

Q34369987-17BA9853-1E95-4CE2-BE05-90BA33075119

P478

Q34369987-FAF5133F-9F58-4B67-AD8F-C7F6CACFD3DC

P50

Q34369987-0A77E0EF-2EF1-48D4-ADA9-C7C3153DCDAE

Q34369987-1A7C4DFD-615D-4C5E-8908-EBCC5B763137

Q34369987-7D00E2FF-C644-4EBA-B8DB-A145EF05062E

Q34369987-EA356365-327A-4F49-815C-C2FBF0AA66BB

Q34369987-F14560CC-21B9-43EA-9C55-487699E395BD

P577

Q34369987-1088DA46-6B29-4546-A564-017A8B5C7724

P5875

Q34369987-FB5C7830-5B8F-43A8-8BA9-E3EAF128CF58

P698

Q34369987-082E3456-DE35-4D0F-A540-F5966E1D69C7

P921

Q34369987-A8F8B063-5439-4982-8940-F293A5EC3DA7

P356

GUTJNL-2013-304833

P1433

P1476

A decrease of the butyrate-pro ...... ients with ulcerative colitis.

@en

P2093

Jan Verhaegen

http://www.w3.org/2001/XMLSchema#string

João Sabino

http://www.w3.org/2001/XMLSchema#string

Karolien Claes

http://www.w3.org/2001/XMLSchema#string

Kathleen Machiels

http://www.w3.org/2001/XMLSchema#string

Kristin Verbeke

http://www.w3.org/2001/XMLSchema#string

Marc Ferrante

http://www.w3.org/2001/XMLSchema#string

Marie Joossens

http://www.w3.org/2001/XMLSchema#string

Venessa Eeckhaut

http://www.w3.org/2001/XMLSchema#string

Vera Ballet

http://www.w3.org/2001/XMLSchema#string

P304

1275-1283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2013-304833

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Séverine Vermeire

Vicky De Preter

Filip Van Immerseel

P577

2013-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256489155

http://www.w3.org/2001/XMLSchema#string

P698

24021287

http://www.w3.org/2001/XMLSchema#string

P921